Globus Medical
GMED
370 hedge funds and large institutions have $4.8B invested in Globus Medical in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 112 increasing their positions, 146 reducing their positions, and 35 closing their positions.
1,708% more call options, than puts
Call options by funds: $15.9M | Put options by funds: $880K
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
26% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 35
20% more capital invested
Capital invested by funds: $4.01B → $4.8B (+$788M)
14.24% more ownership
Funds ownership: 91.35% → 105.59% (+14%)
2% more funds holding
Funds holding: 364 → 370 (+6)
23% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 146
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$445M |
| 2 |
JP Morgan Chase
New York
|
+$65.5M |
| 3 |
PIM
Provident Investment Management
Novi,
Michigan
|
+$20.8M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$18.7M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$13.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$22.5M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$16.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16M |
| 4 |
BlackRock
New York
|
-$12M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$9.74M |
GMED Hedge Fund Activity: Q3 2022 in Review
370 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2022, worth a combined $4.8B — up 20% from $4.01B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new GMED positions and 35 closed out — a net gain of 9 holders — while 112 added to existing stakes and 146 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $445M. The largest seller was RTW Investments, cutting an estimated $22.5M.
- 370 institutional investors held Globus Medical (GMED) as of Q3 2022, up from 364 in Q2 2022.
- Funds reported $4.8B of Globus Medical stock for Q3 2022, up 20% quarter-over-quarter.
- 44 funds opened new Globus Medical positions in Q3 2022 and 35 closed out, a net change of +9 holders.
- The largest Globus Medical buyer in Q3 2022 was Janus Henderson Group, an estimated $445M added.
- The largest Globus Medical seller in Q3 2022 was RTW Investments, an estimated $22.5M sold.
Based on aggregated 13F filings for Q3 2022.